Implantable device actuated by manual button clicks for noninvasive self‐drug administration

Abstract Self‐injectable therapy has several advantages in the treatment of metabolic disorders. However, frequent injections with needles impair patient compliance and medication adherence. Therefore, we develop a fully implantable device capable of on‐demand administration of self‐injection drugs via noninvasive manual button clicks on the outer skin. The device is designed to infuse the drug only at the moment of click actuation, which allows for an accurate and reproducible drug infusion, and also prevents unwanted drug leakage. Using a mechanical means of drug infusion, this implantable device does not contain any electronic compartments or batteries, making it compact, and semi‐permanent. When tested in animals, the device can achieve subcutaneous injection‐like pharmacokinetic and pharmacodynamic effects for self‐injection drugs such as exenatide, insulin, and glucagon.

[1]  David R Owens,et al.  Insulin glargine , 2022, Reactions Weekly.

[2]  I. Hirsch,et al.  The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2021, Diabetologia.

[3]  J. Rantanen,et al.  Integration of personalized drug delivery systems into digital health. , 2021, Advanced drug delivery reviews.

[4]  T. Hansen,et al.  An integrative review on facilitators and barriers in delivering and managing injectable therapies in chronic conditions: A part of the ACNAP project ‘injectable medicines among patients with cardiovascular conditions’ , 2020, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[5]  Chang Ho Ahn,et al.  Magnetically-driven implantable pump for on-demand bolus infusion of short-acting glucagon-like peptide-1 receptor agonist. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Yuqing Wang,et al.  Investigation on the Cooperative Grasping Capabilities of Human Thumb and Index Finger , 2019, Front. Neurorobot..

[7]  Chun Gwon Park,et al.  Implantable multireservoir device with stimulus-responsive membrane for on-demand and pulsatile delivery of growth hormone , 2019, Proceedings of the National Academy of Sciences.

[8]  Johan N. Siebert,et al.  A mobile device application to reduce medication errors and time to drug delivery during simulated paediatric cardiopulmonary resuscitation: a multicentre, randomised, controlled, crossover trial. , 2019, The Lancet. Child & adolescent health.

[9]  W. Kernan,et al.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2018, Diabetologia.

[10]  M. Rogers,et al.  The fear of needles: A systematic review and meta‐analysis , 2018, Journal of advanced nursing.

[11]  Guang Wang,et al.  The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case–Control Study , 2018, Diabetes Therapy.

[12]  Shane Saunderson,et al.  Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During Treatment , 2017, Rheumatology and Therapy.

[13]  Young Bin Choy,et al.  Implantable batteryless device for on-demand and pulsatile insulin administration , 2017, Nature Communications.

[14]  J. Lykkesfeldt,et al.  Chronic Hyperinsulinaemic Hypoglycaemia in Rats Is Accompanied by Increased Body Weight, Hyperleptinaemia, and Decreased Neuronal Glucose Transporter Levels in the Brain , 2017, International journal of endocrinology.

[15]  M. Liang,et al.  Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences , 2016, Current Rheumatology Reports.

[16]  T. Okamura,et al.  Relationship between outpatient visit frequency and hypertension control: a 9-year occupational cohort study , 2016, Hypertension Research.

[17]  Ellis Meng,et al.  A Wireless Implantable Micropump for Chronic Drug Infusion Against Cancer. , 2016, Sensors and actuators. A, Physical.

[18]  Hairong Zheng,et al.  A Disposable Microfluidic Device for Controlled Drug Release from Thermal-Sensitive Liposomes by High Intensity Focused Ultrasound , 2015, Theranostics.

[19]  H. Miura Historical Changes in Home Care Service and Its Future Challenges. , 2015, Japan Medical Association journal : JMAJ.

[20]  Thomas Stieglitz,et al.  Biocompatibility evaluation of parylene C and polyimide as substrates for peripheral nerve interfaces , 2015, 2015 7th International IEEE/EMBS Conference on Neural Engineering (NER).

[21]  M. Trautmann,et al.  Five-year efficacy and safety data of exenatide once weekly: long-term results from the DURATION-1 randomized clinical trial. , 2015, Mayo Clinic proceedings.

[22]  A. T. Sidambe,et al.  Biocompatibility of Advanced Manufactured Titanium Implants—A Review , 2014, Materials.

[23]  Zhigang Suo,et al.  Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy , 2014, Proceedings of the National Academy of Sciences.

[24]  Robert Langer,et al.  Near-infrared–actuated devices for remotely controlled drug delivery , 2014, Proceedings of the National Academy of Sciences.

[25]  Youxin Li,et al.  Effect of water on exenatide acylation in poly(lactide-co-glycolide) microspheres. , 2013, International journal of pharmaceutics.

[26]  Yeun-Ho Joung,et al.  Development of Implantable Medical Devices: From an Engineering Perspective , 2013, International neurourology journal.

[27]  R. Stout,et al.  Jet injection devices for the needle-free administration of compounds, vaccines, and other agents. , 2013, International journal of pharmaceutical compounding.

[28]  R. Dore Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis , 2013, Patient preference and adherence.

[29]  J. Meier GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus , 2012, Nature Reviews Endocrinology.

[30]  Michael E. Cobble,et al.  Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers , 2012, Vascular health and risk management.

[31]  Andrew Taberner,et al.  Needle-free jet injection using real-time controlled linear Lorentz-force actuators. , 2012, Medical engineering & physics.

[32]  Robert Langer,et al.  Reservoir-based drug delivery systems utilizing microtechnology. , 2012, Advanced drug delivery reviews.

[33]  M. Cypress,et al.  Translating the Research in Insulin Injection Technique , 2012, The Diabetes educator.

[34]  Robert Langer,et al.  First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip , 2012, Science Translational Medicine.

[35]  N. Tan,et al.  Initiation of insulin for type 2 diabetes mellitus patients: what are the issues? A qualitative study. , 2011, Singapore medical journal.

[36]  A. Turchin,et al.  Encounter frequency and serum glucose level, blood pressure, and cholesterol level control in patients with diabetes mellitus. , 2011, Archives of internal medicine.

[37]  M. Taskinen,et al.  Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes , 2011, Diabetes Care.

[38]  Stephanie W. Watts,et al.  Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO® Micro Infusion Pump: Programmable, Refillable, and Implantable , 2011, Front. Pharmacol..

[39]  M. S. Lewis,et al.  Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes , 2011, Annals of Internal Medicine.

[40]  D. Keininger,et al.  Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ) , 2011, Health and quality of life outcomes.

[41]  S. Ratcliffe,et al.  Needle Anxiety in Children With Type 1 Diabetes and Their Mothers , 2011, MCN. The American journal of maternal child nursing.

[42]  Michael A. Gibney,et al.  Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations , 2010, Current medical research and opinion.

[43]  A. Lugaresi,et al.  Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study , 2010, BMC neurology.

[44]  L. Pinchuk,et al.  Evaluation of an integrated orbital tissue expander in congenital anophthalmos: report of preliminary clinical experience. , 2010, American journal of ophthalmology.

[45]  W. Kenneth Ward,et al.  Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes , 2010, Diabetes Care.

[46]  J. Baynes,et al.  Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. , 2010, Biochemical and biophysical research communications.

[47]  R. Rubin,et al.  Correlates of Insulin Injection Omission , 2010, Diabetes Care.

[48]  B.-L. Yu,et al.  Cholesterol imbalance in adipocytes: a possible mechanism of adipocytes dysfunction in obesity , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[49]  B. Hartmann,et al.  Long‐term exendin‐4 treatment delays natural deterioration of glycaemic control in diabetic Goto–Kakizaki rats , 2009, Diabetes, obesity & metabolism.

[50]  M. Linder,et al.  In vivo reactions in mice and in vitro reactions in feline cells to implantable microchip transponders with different surface materials , 2009, Veterinary Record.

[51]  J. Rosenstock,et al.  Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) , 2009, The Lancet.

[52]  R. Khandekar,et al.  Regular visits to a diabetes clinic were associated with lower magnitude of visual disability and diabetic retinopathy-a hospital-based historical cohort study in yemen. , 2009, Diabetes technology & therapeutics.

[53]  D. Drucker,et al.  Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study , 2008, The Lancet.

[54]  A. Fischer,et al.  Hematoxylin and eosin staining of tissue and cell sections. , 2008, CSH protocols.

[55]  A. Morris,et al.  Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. , 2007, QJM : monthly journal of the Association of Physicians.

[56]  D. Cox,et al.  Managing self-injection difficulties in patients with relapsing-remitting multiple sclerosis. , 2006, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[57]  A. Young,et al.  Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures , 2006, International Journal of Obesity.

[58]  A. Baron,et al.  Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight. , 2005, Endocrinology.

[59]  D. Mohr,et al.  Self-Injection Anxiety Training: a treatment for patients unable to self-inject injectable medications , 2005, Multiple sclerosis.

[60]  R. Gemperli,et al.  Evaluation of Cutaneous Abdominal Wall Sensibility After Abdominoplasty , 2005, Aesthetic Plastic Surgery.

[61]  S. Cuzzocrea,et al.  Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. , 2005, Diabetes.

[62]  D. Mohr,et al.  Managing difficulties with adherence to injectable medications due to blood, injection, and injury phobia and self-injection anxiety , 2003 .

[63]  I. Hirsch,et al.  Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. , 2003, JAMA.

[64]  Edmond Sabo,et al.  Fear of injections in young adults: prevalence and associations. , 2003, The American journal of tropical medicine and hygiene.

[65]  B. Klosterhalfen,et al.  Histological analysis of silicone breast implant capsules and correlation with capsular contracture. , 2003, Biomaterials.

[66]  D. Mohr,et al.  Teaching patients to self-inject: pilot study of a treatment for injection anxiety and phobia in multiple sclerosis patients prescribed injectable medications. , 2002, Journal of behavior therapy and experimental psychiatry.

[67]  R. Newson,et al.  Injection related anxiety in insulin-treated diabetes. , 1999, Diabetes research and clinical practice.

[68]  J. Holst,et al.  Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7–36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats , 1999, Diabetologia.

[69]  B. Willershausen,et al.  Fear of dental treatment and its possible effects on oral health. , 1999, European journal of medical research.

[70]  P. Casadio,et al.  Subcutaneous administration of a depot gonadotropin-releasing hormone agonist induces profound reproductive axis suppression in women. , 1998, Fertility and sterility.

[71]  Georg Brabant,et al.  Pulsatile patterns in hormone secretion , 1992, Trends in Endocrinology & Metabolism.

[72]  M J Lichtenstein,et al.  Visit frequency for essential hypertension: observed associations. , 1989, The Journal of family practice.

[73]  W. Crowley,et al.  Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. , 1986, Endocrine reviews.

[74]  Yihua Chen,et al.  A thermo-degradable hydrogel with light-tunable degradation and drug release. , 2017, Biomaterials.

[75]  Christian Lovis,et al.  Improving Drugs Administration Safety in Pediatric Resuscitation Using Mobile Technology , 2016, Nursing Informatics.

[76]  D. Jain,et al.  Implantable Drug Delivery System: A Review , 2012 .

[77]  A. Cheng,et al.  Emergency treatment of anaphylaxis in infants and children. , 2011, Paediatrics & child health.

[78]  H. Bilo,et al.  Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump , 2008, Langenbeck's Archives of Surgery.